S. Hannick

发表

Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management.

A. Gomtsyan, Jill M. Wetter, J. Sullivan, 2008, Journal of medicinal chemistry.

Stereocontrolled synthesis of C2-symmetric and pseudo-C2-symmetric diamino alcohols and diols for use in HIV protease inhibitors

D. Norbeck, D. Kempf, R. Henry, 1992 .

Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) Inhibitors.

Justin D Dietrich, A. Vasudevan, J. Sydor, 2018, Journal of medicinal chemistry.

Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.

A. Gomtsyan, Jill M. Wetter, Chih-Hung Lee, 2005, Journal of medicinal chemistry.

Potent, orally active heterocycle-based combretastatin A-4 analogues: synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation.

S. Rosenberg, R. B. Credo, H. Sham, 2002, Journal of medicinal chemistry.

An improved procedure for the Blaise reaction: a short, practical route to the key intermediates of the saxitoxin synthesis

S. Hannick, Y. Kishi, 1983 .

Efficient syntheses of protected (2s,3s)-2,3-bis(hydroxymethyl)cyclobutanone, key intermediates for the synthesis of chiral carbocyclic analogues of oxetanocin

S. Hannick, C. Hsiao, 1990 .

A stereoselective and scalable synthesis of a conformationally constrained S1P1 agonist

R. Stoffel, K. Cusack, S. Hannick, 2009 .

Discovery of TRPV1 antagonist ABT-116.

Chih-Hung Lee, R. Moreland, P. Honore, 2010, Bioorganic & medicinal chemistry letters.

Discovery of TRPV1 antagonist ABT-116.

Chih-Hung Lee, R. Moreland, P. Honore, 2010, Bioorganic & medicinal chemistry letters.